NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.1B | $2.3B | $2.4B | $2.5B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $389.7M | $343.0M | $343.5M | $340.6M | $366.5M | $338.2M |
| Net income | $319.5M | $268,550.00 | $249,624.00 | $272,509.00 | $301,999.00 | $265,238.00 |
| Diluted EPS | $19.48 | $16.85 | $16.53 | $17.93 | $19.89 | $18.34 |
| Operating cash flow | $489.3M | $308.6M | $309.9M | $330.3M | $417.5M | $388.3M |
| Free cash flow | $430.5M | $249.9M | $252.6M | $273.4M | $368.0M | $325.5M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 18.7% | 16.0% | 16.1% | 15.0% | 15.1% | 13.4% |
| Net margin | 15.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $595.9M | $606.2M | $640.0M | $646.9M | $618.8M | $624.9M | $639.3M | $657.5M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $88.1M | $92.2M | $113.9M | $94.8M | $68.1M | $74.8M | $100.7M | $84.6M |
| Net income | $70.9M | $75.8M | -$211.4M | $71.8M | $52.5M | $64.2M | -$188.2M | $66.3M |
| Diluted EPS | $4.65 | $5.00 | $6.00 | $4.86 | $3.57 | $4.46 | $5.45 | $4.84 |
| Operating cash flow | $77.5M | $90.5M | $164.9M | $32.7M | $138.6M | $83.4M | $133.5M | $88.2M |
| Free cash flow | $66.5M | $77.0M | $152.2M | $19.5M | $122.8M | $66.0M | $117.2M | $71.1M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 14.8% | 15.2% | 17.8% | 14.6% | 11.0% | 12.0% | 15.7% | 12.9% |
| Net margin | 11.9% | 12.5% | -33.0% | 11.1% | 8.5% | 10.3% | -29.4% | 10.1% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-09 | LINDELL ANDREA R | Sale | 1,347 | $447.33 | $602,553.51 | filing |
| 2026-05-29 | WALSH GEORGE J III | Sale | 500 | $437.83 | $218,915.00 | filing |
| 2026-05-18 | Mount John Meredith Jr. | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-18 | McCarthy Eileen P | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-18 | LINDELL ANDREA R | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-18 | Heaney Christopher J | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-18 | GRACE PATRICK P | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-18 | DeLyons Ron | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-18 | WALSH GEORGE J III | Award | 386 | $440.77 | $170,137.22 | filing |
| 2026-05-08 | GRACE PATRICK P | Sale | 60 | $425.78 | $25,546.80 | filing |
| 2026-05-01 | MCNAMARA KEVIN J· president and CEO | Sale | 2,000 | $421.13 | $842,260.00 | filing |
| 2026-03-27 | MCNAMARA KEVIN J· president and CEO | Sale | 1,500 | $369.37 | $554,055.00 | filing |
| 2026-03-12 | MCNAMARA KEVIN J· president and CEO | Sale | 2,000 | $403.18 | $806,360.00 | filing |
| 2026-02-13 | MCNAMARA KEVIN J· president and CEO | Option exercise | 2,714 | $469.56 | $1.3M | filing |
| 2026-02-13 | MCNAMARA KEVIN J· president and CEO | Tax withholding | 1,192 | $469.56 | $559,715.52 | filing |
| 2026-02-13 | LEE SPENCER S· executive vice president | Option exercise | 499 | $469.56 | $234,310.44 | filing |
| 2026-02-13 | Witzeman Michael D· VP & Chief Financial Officer | Option exercise | 413 | $469.56 | $193,928.28 | filing |
| 2026-02-13 | Judkins Brian C· VP and Chief Legal Officer | Option exercise | 351 | $469.56 | $164,815.56 | filing |
| 2026-02-13 | Wherley Joel L· CEO - Vitas Healthcare | Option exercise | 273 | $469.56 | $128,189.88 | filing |
| 2026-02-13 | HUTTON THOMAS C· vice president | Option exercise | 199 | $469.56 | $93,442.44 | filing |
| 2026-02-13 | LEE SPENCER S· executive vice president | Tax withholding | 154 | $469.56 | $72,312.24 | filing |
| 2026-02-13 | Witzeman Michael D· VP & Chief Financial Officer | Tax withholding | 120 | $469.56 | $56,347.20 | filing |
| 2026-02-13 | Judkins Brian C· VP and Chief Legal Officer | Tax withholding | 102 | $469.56 | $47,895.12 | filing |
| 2026-02-13 | Wherley Joel L· CEO - Vitas Healthcare | Tax withholding | 80 | $469.56 | $37,564.80 | filing |
| 2026-02-13 | HUTTON THOMAS C· vice president | Tax withholding | 72 | $469.56 | $33,808.32 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.